8-K: Cardinal Health Issues $1.15 Billion in Senior Notes

Sentiment:

Debt Issuance Agreement


Cardinal Health has successfully priced and issued $1.15 billion in senior notes, split between 2029 and 2034 maturities.

Capital raiseCardinal Health has raised $1.15 billion through the issuance of senior notes.The proceeds from the offering will be used for general corporate purposes.

Summary

  • Cardinal Health, Inc. has issued $650 million in 5.125% senior notes due in 2029 and $500 million in 5.450% senior notes due in 2034.
  • The notes were issued under an existing indenture, supplemented by a new first supplemental indenture dated February 20, 2024.
  • The 2029 notes mature on February 15, 2029, and the 2034 notes mature on February 15, 2034.
  • Interest on both series of notes is payable semi-annually on February 15 and August 15, starting August 15, 2024.
  • The company may redeem the notes at its option prior to specific par call dates, with a redemption price calculated based on a treasury rate plus a spread.
  • The 2029 notes have a par call date of January 15, 2029, and the 2034 notes have a par call date of November 15, 2033.
  • In the event of a change of control and a below investment grade rating event, the company is required to offer to repurchase the notes at 101% of their principal amount plus accrued interest.

Sentiment

Score: 7

Explanation: The document is a standard financial transaction, with no significant positive or negative surprises. The terms are reasonable and the company is able to access the debt markets. The sentiment is neutral to slightly positive.

Positives

  • The issuance provides Cardinal Health with a significant amount of capital.
  • The notes have fixed interest rates, providing predictability for the company's financing costs.
  • The notes have a change of control provision, which protects investors in the event of a takeover.
  • The notes are issued under an existing indenture, which simplifies the process.

Negatives

  • The company is taking on additional debt, which increases its financial leverage.
  • The notes are subject to redemption risk, which could impact investors' returns.
  • The company is subject to interest rate risk, as the notes are tied to treasury rates.

Risks

  • Changes in interest rates could affect the redemption price of the notes.
  • A change of control and a downgrade below investment grade could trigger a repurchase event.
  • The company's financial performance could impact its ability to service the debt.
  • The company's credit rating could be downgraded, which would increase its borrowing costs.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but it does outline the terms and conditions of the newly issued debt, which will impact the company's financial structure going forward.

Industry Context

The issuance of senior notes is a common financing method for large corporations like Cardinal Health to raise capital for general corporate purposes, acquisitions, or refinancing existing debt. The interest rates and terms of the notes are reflective of the current market conditions and the company's credit rating.

Comparison to Industry Standards

  • The interest rates on the notes are consistent with current market rates for investment-grade corporate debt.
  • The make-whole call provisions are standard for corporate bonds, allowing the issuer to redeem the notes early at a premium.
  • The change of control provision is a common feature in debt issuances to protect investors in the event of a merger or acquisition.
  • Comparable companies in the healthcare distribution sector, such as McKesson and AmerisourceBergen, also utilize debt financing as part of their capital structure.

Stakeholder Impact

  • Shareholders will be impacted by the increased debt on the company's balance sheet.
  • Creditors will be impacted by the new debt issuance.
  • Employees will be indirectly impacted by the company's financial decisions.
  • Customers and suppliers will not be directly impacted by this transaction.

Next Steps

  • The company will make semi-annual interest payments on the notes.
  • The company may choose to redeem the notes at its option prior to the par call dates.
  • The company will be required to offer to repurchase the notes in the event of a change of control and a below investment grade rating event.

Key Dates

DateDescription
June 2, 2008Date of the original Indenture between Cardinal Health and The Bank of New York Mellon Trust Company, N.A.
February 14, 2024Date of the Underwriting Agreement for the issuance of the notes.
February 20, 2024Date of the First Supplemental Indenture and the closing date for the issuance of the notes.
August 15, 2024First interest payment date for both the 2029 and 2034 notes.
January 15, 2029Par call date for the 2029 notes.
February 15, 2029Maturity date for the 2029 notes.
November 15, 2033Par call date for the 2034 notes.
February 15, 2034Maturity date for the 2034 notes.

Keywords

senior notes, debt financing, fixed income, corporate bonds, Cardinal Health, indenture, redemption, change of control, interest rate, investment grade

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.